Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03812614 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
444
Enrollment target

NCT03812614: Completed NA study, sponsored by University of Pittsburgh.

NCT03812614 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 444 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03812614, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
444 participants
Enrollment target

Study Summary

The objective of this study is to compare the effectiveness of a novel program-Family Support for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and support (I-DSMES).

Primary Outcome

Hemoglobin A1c (HbA1c, percent) was measured via finger stick performed by a study research assistant, by a clinician as a part of the patients' regular care, or by patients via home test kit. For analysis, HbA1c first was examined graphically to understand how it changed over time. Main analyses then were conducted using linear mixed-effects models, with 12-month HbA1c values included in the models to increase the power to estimate changes over the initial 6 months. Adjusted outcome and effect

Interventions

  • BEHAVIORAL FAM ACT
  • BEHAVIORAL I-DSMES

Trial Details

FieldValue
Enrollment Target 444 participants
Start Date 2019-09-23
Est. Completion 2023-12-31
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03812614 record still lists

NCT03812614 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which FAM ACT is the first listed.

NCT03812614 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03812614 about?

NCT03812614 is a clinical study titled "Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support". The objective of this study is to compare the effectiveness of a novel program-Family Support for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and support (I-DSMES).

What is the current status of trial NCT03812614?

This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2019-09-23. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT03812614?

The interventions under investigation include: FAM ACT (BEHAVIORAL), I-DSMES (BEHAVIORAL).

Who is sponsoring clinical trial NCT03812614?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03812614's enrollment target sits among peer trials

444 233rd of 2000 higher than 1,768 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06348394 · 444 participants · NA

    Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

  • NCT06700343 · 444 participants · Phase 3

    Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  • NCT01280994 · 445 participants · Phase 2

    Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

  • NCT03504800 · 445 participants

    OCT in Diagnosis of Irregular Corneas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03812614, the US trial registry maintained by the National Library of Medicine. NCT03812614 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.